These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15654550)

  • 1. Secondary prevention after ischemic stroke. Evolution over time in practice.
    Girot M; Mackowiak-Cordoliani MA; Deplanque D; Hénon H; Lucas C; Leys D
    J Neurol; 2005 Jan; 252(1):14-20. PubMed ID: 15654550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of secondary vascular prevention in practice after cerebral ischemia and coronary heart disease.
    Girot M; Deplanque D; Pasquier F; Destée A; Leys D
    J Neurol; 2004 May; 251(5):529-36. PubMed ID: 15164184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
    Johnson P; Rosewell M; James MA
    Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke.
    Poudel RS; Thapa L; Shrestha S; Khatiwada D; Upadhyay N; Bhandari TR; Shrestha A
    JNMA J Nepal Med Assoc; 2015; 53(197):5-11. PubMed ID: 26983040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New perspectives on the pharmacotherapy of ischemic stroke.
    Bradberry JC; Fagan SC; Gray DR; Moon YS
    J Am Pharm Assoc (2003); 2004; 44(2 Suppl 1):S46-56; quiz S56-7. PubMed ID: 15095935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke prevention: management of modifiable vascular risk factors.
    Leys D; Deplanque D; Mounier-Vehier C; Mackowiak-Cordoliani MA; Lucas C; Bordet R
    J Neurol; 2002 May; 249(5):507-17. PubMed ID: 12021938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prevention in patients with vascular disease. A population based study on the underuse of recommended medications.
    Béjot Y; Zeller M; Lorgis L; Troisgros O; Aboa-Eboulé C; Osseby GV; Giroud M; Cottin Y
    J Neurol Neurosurg Psychiatry; 2013 Mar; 84(3):348-53. PubMed ID: 23152636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary stroke and its prevention in patients with arterial hypertension].
    Parfenov VA; Gurak SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; (Suppl 14):3-7. PubMed ID: 16184847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure control and risk profile in poststroke survivors: a comparison with the general population.
    Cífková R; Wohlfahrt P; Krajčoviechová A; Jozífová M; Mayer O; Vaněk J; Hlinovský D; Kielbergerová L; Lánská V
    J Hypertens; 2015 Oct; 33(10):2107-14. PubMed ID: 26200884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China.
    Peng B; Ni J; Anderson CS; Zhu Y; Wang Y; Pu C; Wu J; Wang J; Zhou L; Yao M; He J; Shan G; Gao S; Xu W; Cui L;
    Stroke; 2014 Feb; 45(2):515-9. PubMed ID: 24385269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention of ischemic non cardioembolic stroke].
    Armario P; Pinto X; Soler C; Cardona P
    Clin Investig Arterioscler; 2015; 27(6):287-300. PubMed ID: 25771074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypercholesterolemia in patients with diabetes at a family practice office.
    Camenga D; Gill JM
    Del Med J; 2003 Nov; 75(11):415-20. PubMed ID: 14870630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal effects of available drugs for ischemic stroke.
    Chen M; Selim M
    Drugs Today (Barc); 2005 Jun; 41(6):401-9. PubMed ID: 16110347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey.
    Heuschmann PU; Kircher J; Nowe T; Dittrich R; Reiner Z; Cifkova R; Malojcic B; Mayer O; Bruthans J; Wloch-Kopec D; Prugger C; Heidrich J; Keil U
    Eur J Prev Cardiol; 2015 Oct; 22(10):1354-62. PubMed ID: 25139770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypolipemic agents for stroke prevention.
    Leys D; Deplanque D; Lucas C; Bordet R
    Clin Exp Hypertens; 2002; 24(7-8):573-94. PubMed ID: 12450233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance with secondary prevention of ischemic stroke: a prospective evaluation.
    Sappok T; Faulstich A; Stuckert E; Kruck H; Marx P; Koennecke HC
    Stroke; 2001 Aug; 32(8):1884-9. PubMed ID: 11486121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic agents in the prevention of ischemic stroke.
    Bousser MG
    Cerebrovasc Dis; 2009; 27 Suppl 3():12-9. PubMed ID: 19439936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.